
Exemestane (Aromasin) | Cancer information - Cancer Research UK
Exemestane (Aromasin) Exemestane is a type of hormone therapy drug. It is also known as Aromasin. It is a treatment for breast cancer after you have had the menopause (post …
A trial of tamoxifen and exemestane for early breast cancer in post ...
The researchers found that having 5 years of exemestane straight away worked as well as having tamoxifen for 2 to 3 years followed by exemestane. The trial recruited over 9,000 women who …
A trial of exemestane with or without everolimus for breast cancer …
485 women had exemestane and everolimus; 239 had exemestane and a dummy drug (placebo) Women in the everolimus group had more side effects such as sore mouth, a drop in the …
Hormone therapy for breast cancer | Cancer Research UK
exemestane (Aromasin) You are most likely to have anastrozole or letrozole for 5 years. Or you might have one of these drugs for 2 years followed by tamoxifen for 3 years. If you can't have …
A trial looking at everolimus, exemestane and ... - Cancer Research …
Women who had everolimus and exemestane or everolimus on its own had more problems with a sore mouth. This was a common side effect for both groups. Conclusion The trial team found …
A trial looking at exemestane, letrozole and celecoxib before …
Some people taking part had exemestane and some had letrozole. Alongside that, some had celecoxib and some had a dummy drug (placebo). Results A total of 266 women had …
Food and drink to avoid during cancer treatment
Everything you take by mouth, including food, drink and medicine, needs to be absorbed by the body. This process happens in the gut (digestive system).
A trial looking at the effect of exemestane and celecoxib on ductal ...
One was exemestane (Aromasin), a type of hormone therapy called an aromatase inhibitor. The other drug was celecoxib, a COX-2 inhibitor. COX-2 inhibitors block the action of a protein …
A trial of everolimus, letrozole and exemestane for advanced HER2 ...
But everolimus and exemestane didn’t work as well as they had hoped. This is because these women had a number of areas of cancer spread and they had already had everolimus. So, the …
A trial looking at abiraterone with exemestane for breast cancer …
In group 1 you have abiraterone, prednisolone and exemestane. In group 2 you have abiraterone and prednisolone. In group 3 you have exemestane alone. Abiraterone is a tablet. You take 4 …